Duke Cancer Center /ID# 71393

Durham, North Carolina 27710-3000

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Studies at this site

• A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma — Completed